BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scarlett KA, White EZ, Coke CJ, Carter JR, Bryant LK, Hinton CV. Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration. Mol Cancer Res 2018;16:728-39. [PMID: 29330286 DOI: 10.1158/1541-7786.MCR-16-0481] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Farooq Z, Howell LA, Mccormick PJ. Probing GPCR Dimerization Using Peptides. Front Endocrinol 2022;13:843770. [DOI: 10.3389/fendo.2022.843770] [Reference Citation Analysis]
2 Shoeib AM, Benson LN, Mu S, MacMillan-Crow LA, Prather PL. Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death. Int J Mol Sci 2022;23:3049. [PMID: 35328467 DOI: 10.3390/ijms23063049] [Reference Citation Analysis]
3 Guo P, Tai Y, Wang M, Sun H, Zhang L, Wei W, Xiang YK, Wang Q. Gα12 and Gα13: Versatility in Physiology and Pathology. Front Cell Dev Biol 2022;10:809425. [PMID: 35237598 DOI: 10.3389/fcell.2022.809425] [Reference Citation Analysis]
4 Lian J, Casari I, Falasca M. Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract. Pharmacol Res 2021;175:106025. [PMID: 34883211 DOI: 10.1016/j.phrs.2021.106025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Iozzo M, Sgrignani G, Comito G, Chiarugi P, Giannoni E. Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches. Cells 2021;10:3396. [PMID: 34943903 DOI: 10.3390/cells10123396] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 O'Dorisio TM, Harris AG, O'Dorisio MS. Evolution of Neuroendocrine Tumor Therapy. Surg Oncol Clin N Am 2020;29:145-63. [PMID: 32151353 DOI: 10.1016/j.soc.2019.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Braile M, Marcella S, Marone G, Galdiero MR, Varricchi G, Loffredo S. The Interplay between the Immune and the Endocannabinoid Systems in Cancer. Cells 2021;10:1282. [PMID: 34064197 DOI: 10.3390/cells10061282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
8 Moreno E, Cavic M, Canela EI. Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease. Int J Mol Sci 2021;22:3661. [PMID: 33915889 DOI: 10.3390/ijms22073661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chen L, Chen Q, Wu Y, Zhu M, Hu J, Zhuang Z. MTSS1 inhibits colorectal cancer metastasis by regulating the CXCR4/CXCL12 signaling axis. Int J Mol Med 2021;47:65. [PMID: 33649808 DOI: 10.3892/ijmm.2021.4898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yadav-Samudrala BJ, Fitting S. Mini-review: The therapeutic role of cannabinoids in neuroHIV. Neurosci Lett 2021;750:135717. [PMID: 33587986 DOI: 10.1016/j.neulet.2021.135717] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Moreno E, Cavic M, Krivokuca A, Canela EI. The Interplay between Cancer Biology and the Endocannabinoid System-Significance for Cancer Risk, Prognosis and Response to Treatment. Cancers (Basel) 2020;12:E3275. [PMID: 33167409 DOI: 10.3390/cancers12113275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
12 Gao X, Cheng YH, Enten GA, DeSantis AJ, Gaponenko V, Majetschak M. Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CXC motif) receptor 4. J Biol Chem 2020;295:14893-905. [PMID: 32839271 DOI: 10.1074/jbc.RA120.015355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
13 White EZ, Pennant NM, Carter JR, Hawsawi O, Odero-Marah V, Hinton CV. Serum deprivation initiates adaptation and survival to oxidative stress in prostate cancer cells. Sci Rep 2020;10:12505. [PMID: 32719369 DOI: 10.1038/s41598-020-68668-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
14 Leuti A, Fazio D, Fava M, Piccoli A, Oddi S, Maccarrone M. Bioactive lipids, inflammation and chronic diseases. Adv Drug Deliv Rev 2020;159:133-69. [PMID: 32628989 DOI: 10.1016/j.addr.2020.06.028] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 23.0] [Reference Citation Analysis]
15 Kovalchuk O, Kovalchuk I. Cannabinoids as anticancer therapeutic agents. Cell Cycle 2020;19:961-89. [PMID: 32249682 DOI: 10.1080/15384101.2020.1742952] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
16 Xu M, Li Y, Li W, Zhao Q, Zhang Q, Le K, Huang Z, Yi P. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database. Front Med (Lausanne) 2020;7:64. [PMID: 32195260 DOI: 10.3389/fmed.2020.00064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
17 Laezza C, Pagano C, Navarra G, Pastorino O, Proto MC, Fiore D, Piscopo C, Gazzerro P, Bifulco M. The Endocannabinoid System: A Target for Cancer Treatment. Int J Mol Sci 2020;21:E747. [PMID: 31979368 DOI: 10.3390/ijms21030747] [Cited by in Crossref: 30] [Cited by in F6Publishing: 45] [Article Influence: 15.0] [Reference Citation Analysis]
18 Gad AA, Balenga N. The Emerging Role of Adhesion GPCRs in Cancer. ACS Pharmacol Transl Sci 2020;3:29-42. [PMID: 32259086 DOI: 10.1021/acsptsci.9b00093] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
19 Ullah TR. The role of CXCR4 in multiple myeloma: Cells' journey from bone marrow to beyond. J Bone Oncol 2019;17:100253. [PMID: 31372333 DOI: 10.1016/j.jbo.2019.100253] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
20 Wang LX, Wan C, Dong ZB, Wang BH, Liu HY, Li Y. Integrative Analysis of Long Noncoding RNA (lncRNA), microRNA (miRNA) and mRNA Expression and Construction of a Competing Endogenous RNA (ceRNA) Network in Metastatic Melanoma. Med Sci Monit 2019;25:2896-907. [PMID: 31004080 DOI: 10.12659/MSM.913881] [Cited by in Crossref: 24] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
21 Moreno E, Cavic M, Krivokuca A, Casadó V, Canela E. The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet? Front Pharmacol 2019;10:339. [PMID: 31024307 DOI: 10.3389/fphar.2019.00339] [Cited by in Crossref: 50] [Cited by in F6Publishing: 61] [Article Influence: 16.7] [Reference Citation Analysis]
22 Blasco-Benito S, Moreno E, Seijo-Vila M, Tundidor I, Andradas C, Caffarel MM, Caro-Villalobos M, Urigüen L, Diez-Alarcia R, Moreno-Bueno G, Hernández L, Manso L, Homar-Ruano P, McCormick PJ, Bibic L, Bernadó-Morales C, Arribas J, Canals M, Casadó V, Canela EI, Guzmán M, Pérez-Gómez E, Sánchez C. Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer. Proc Natl Acad Sci U S A 2019;116:3863-72. [PMID: 30733293 DOI: 10.1073/pnas.1815034116] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
23 Caggia S, Chunduri H, Millena AC, Perkins JN, Venugopal SV, Vo BT, Li C, Tu Y, Khan SA. Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells. J Cell Physiol 2018;234:802-15. [PMID: 30078221 DOI: 10.1002/jcp.26894] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]